NASDAQ:EYEG
Delisted
Eyegate Pharmaceuticals Stock News
$0.141
-0.0080 (-5.37%)
At Close: Aug 17, 2022
Monday Minutes: Economic Snapshot
08:44am, Monday, 15'th Jun 2020
A summary of last week’s major macroeconomic updates and indicators brought to you on one page for your convenience. June 9 to June 15 Coverage: MPED allocated EGP 8.5 billion for the establishment
EyeGate Pharma Receives Positive Feedback from FDA Regarding Ocular Bandage Gel Packaging
10:55am, Thursday, 11'th Jun 2020
OBG is being developed for corneal wound repair post photorefractive keratectomy ("PRK") surgery and for dry eye patients with punctate epitheliopathies ("PE"). OBG does not include a preservative, w
Zacks: Brokerages Anticipate Eastgroup Properties Inc (NYSE:EGP) Will Post Quarterly Sales of $88.06 Million
04:12am, Wednesday, 10'th Jun 2020
Equities research analysts forecast that Eastgroup Properties Inc (NYSE:EGP) will announce $88.06 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have i
EyeGate Pharma to Present at Jefferies 2020 Virtual Healthcare Conference
10:55am, Monday, 01'st Jun 2020
EyeGate's lead product, Ocular Bandage Gel ("OBG"), is based on a modified form of the natural polymer hyaluronic acid. The product is applied as a clear topical gel, to the damaged ocular surface an
Placenta Growth Factor Pipeline Review, H1 2020: Companies Involved in Therapeutics Development - ResearchAndMarkets.com
12:00am, Thursday, 21'st May 2020
The
Ocular Inflammation Treatment Market Analysis as per the Latest Coronavirus Impact
03:06pm, Wednesday, 20'th May 2020
May 20, 2020 (Heraldkeepers) --
New York, May 20, 2020: You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports...
EYEG: Solid results – moving towards regulatory filings later this year
01:11pm, Tuesday, 19'th May 2020
By Beth Senko, CFA NASDAQ:EYEG READ THE FULL EYEG RESEARCH REPORT EyeGate Pharmaceuticals (NASDAQ:EYEG) is sticking to its business plan, despite any disruption from the pandemic. Meetings with regula
EyeGate Pharma Reports First Quarter 2020 Financial Results and Provides Business Update
08:15pm, Wednesday, 06'th May 2020
This data confirmed the ability of our OBG eye drop to treat patients with dry eye, which is a large market opportunity in the United States. OBG also recently demonstrated statistical significance i
EYEG: An Active 2020 with More to Come
01:10pm, Wednesday, 06'th May 2020
By Beth Senko, CFA NASDAQ:EYEG READ THE FULL EYEG RESEARCH REPORT EyeGate Pharmaceuticals (NASDAQ:EYEG) is a late-stage clinical company developing better solutions to current treatments for post-surg
Global Macular Edema Therapeutics Market 2020 Segmentation Analysis, Key Players, Industry Share and Forecast by 2025
01:29pm, Sunday, 03'rd May 2020
May 03, 2020 (CDN Newswire via Comtex) --
A recent comprehensive study titled Global Macular Edema Therapeutics Market 2020 by Company, Regions, Type and...
Company News for Apr 1, 2020
01:04pm, Wednesday, 01'st Apr 2020
Companies In The News Are: KNSA, EYEG, VBIV, EYES
Company News for Apr 1, 2020
01:04pm, Wednesday, 01'st Apr 2020
Companies In The News Are: KNSA, EYEG, VBIV, EYES
Mid-Afternoon Market Update: Dow Falls Over 100 Points; Amarin Shares Slide
06:36pm, Tuesday, 31'st Mar 2020
Toward the end of trading Tuesday, the Dow traded down 0.63% to 22,186.76 while the NASDAQ fell 0.20% to 7,758.84. The S&P also fell, dropping 0.68% to 2,608.79.
The U.S. is...
56 Stocks Moving In Tuesday's Mid-Day Session
04:27pm, Tuesday, 31'st Mar 2020
Gainers
SG Blocks, Inc. (NASDAQ: SGBX) shares climbed 113.6% to $4.40 after the company reported Q4 results.
IZEA Worldwide, Inc. (NASDAQ: IZEA) jumped 41% to $0.2650 following...
Mid-Day Market Update: SG Blocks Surges Following Q4 Results; Seanergy Maritime Shares Plummet
04:03pm, Tuesday, 31'st Mar 2020
Midway through trading Tuesday, the Dow traded up 0.23% to 22,379.93 while the NASDAQ rose 0.80% to 7,836.42. The S&P also rose, gaining 0.20% to 2,631.27.
The U.S. is now the...